Daily Arxiv

This page organizes papers related to artificial intelligence published around the world.
This page is summarized using Google Gemini and is operated on a non-profit basis.
The copyright of the paper belongs to the author and the relevant institution. When sharing, simply cite the source.

Assay2Mol: large language model-based drug design using BioAssay context

Created by
  • Haebom

Author

Yifan Deng, Spencer S. Ericksen, Anthony Gitter

Outline

Assay2Mol is a large-scale language model-based workflow that aims to accelerate early-stage drug discovery by leveraging the vast existing data set of biochemical screening assays. It searches for assays that engage targets similar to existing targets and uses the retrieved assay screening data to generate candidate molecules through contextual learning. By leveraging information such as biological mechanisms and experimental screening protocols in unstructured text, Assay2Mol outperforms existing machine learning approaches that simply use the target protein structure, accelerating the generation of highly synthetically viable molecules.

Takeaways, Limitations

Takeaways:
We demonstrate that the new drug development process can be streamlined by leveraging existing unstructured text data.
It can generate molecules with higher performance and higher synthesis potential than existing machine learning methods.
It presents new possibilities in early-stage drug discovery.
Limitations:
Lack of detailed information about the size and diversity of the dataset used to evaluate the performance of Assay2Mol.
Verification of the actual efficacy and safety of the generated molecules is required.
Further research is needed on the model's generalization performance and applicability to various targets.
👍